Synapse - Kathryn Arbour

Results (89)

Impact of MTAP deletion on immunotherapy outcomes in patients with mesothelioma

Meeting Abstract

Ross, J.; Ortiz, E.; Barraza, G.; Mayoral, M.; Ginsberg, M. S.; Luongo, A.; Arfe, A.; Zauderer, M. G.; Adusumilli, P. S.; Eckert, S.; more...
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save

Intracranial disease control and survival among patients with KRAS-mutant lung adenocarcinoma and brain metastases treated with stereotactic radiosurgery

Journal Article

Gaeta, B.; Eichholz, J. E.; Walch, H.; Ilica, A. T.; Boe, L.; Kratochvil, L.; Yu, Y.; Gomez, D. R.; Imber, B. S.; Li, B. T.; more...
International Journal of Radiation Oncology, Biology, Physics (2025)

Fulltext@MSK | Save

Safety and clinical activity of daraxonrasib (RMC-6236) in RAS mutant non-small cell lung cancer (NSCLC)

Meeting Abstract

Punekar, S. R.; Hong, D. S.; Luo, J.; Ou, S. H. I.; Johnson, M. L.; Spira, A.; Garrido-Laguna, I.; Goldman, J. W.; Herzberg, B.; Saltos, A.; more...
Journal of Thoracic Oncology (2025)

Fulltext@MSK | Save

Enhancing enrollment to 1L NSCLC trials by allowing 1 prior cycle of standard of care (SOC): SUNRAY-01 experience

Meeting Abstract

Hochmair, M. J.; Arbour, K. C.; Negrao, M. V.; Cappuzzo, F.; Dingemans, A. M. C.; Girard, N.; Gronberg, B. H.; Leal, T. A.; Lindsay, C.; Lu, S.; more...
Journal of Thoracic Oncology (2025)

Fulltext@MSK | Save

Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors

Journal Article

Di Federico, A.; Hong, L.; Elkrief, A.; Thummalapalli, R.; Cooper, A. J.; Ricciuti, B.; Digumarthy, S.; Alessi, J. V.; Gogia, P.; Pecci, F.; more...
Annals of Oncology (2025)

Fulltext@MSK | Save

RRAS and RRAS2 mutations are oncogenic drivers in lung cancer and are sensitive to the PAN-RAS inhibitor RMC-6236

Meeting Abstract

Pfeil, A. J.; Zhang, T.; Febres-Aldana, C. A.; Cheng, R.; Mattar, M. S.; Arbour, K.; Ladanyi, M.; Yang, S. R.; Somwar, R.
Journal of Thoracic Oncology (2024)

Fulltext@MSK | Save

Results from CA240-0007, a phase 1/2 multiple expansion cohort study of BMS-986504 in patients (pts) with advanced solid tumors with homozygous MTAP deletion (MTAP-del)

Meeting Abstract

Rodon, J.; Jänne, P. A.; Leventakos, K.; George, B.; Henry, J. T.; Johnson, M. L.; Papadopoulos, K. P.; Batista, A. I.; Spira, C. P.; Zhao, Y.; more...
European Journal of Cancer (2024)

Fulltext@MSK | Save

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Journal Article

Skoulidis, F.; Araujo, H. A.; Do, M. T.; Qian, Y.; Sun, X.; Cobo, A. G.; Le, J. T.; Montesion, M.; Palmer, R.; Jahchan, N.; more...
Nature (2024)

Fulltext@MSK | Save

SUNRAY-01, a pivotal, global study of olomorasib (LY3537982) in combination with pembrolizumab with or without chemotherapy for 1L treatment in KRAS G12C-mutant advanced NSCLC